Giuliano Malloci
Overview
Explore the profile of Giuliano Malloci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basciu A, Athar M, Kurt H, Neville C, Malloci G, Muredda F, et al.
J Chem Inf Model
. 2025 Feb;
65(4):2052-2065.
PMID: 39907634
Knowledge of the structures formed by proteins and small molecules is key to understand the molecular principles of chemotherapy and for designing new and more effective drugs. During the early...
2.
Irianti M, Malloci G, Ruggerone P, Lodinsky E, Vincken J, Pos K, et al.
Biomed Pharmacother
. 2024 Dec;
182():117779.
PMID: 39731937
Escherichia coli is amongst the most frequent causative agent of nosocomial infections and the overexpression of the efflux pump gene acrB plays a major role in its resistance to various...
3.
Ozturk I, Gervasoni S, Guccione C, Bosin A, Vargiu A, Ruggerone P, et al.
Molecules
. 2024 Sep;
29(18).
PMID: 39339411
Radiopharmaceuticals are currently a key tool in cancer diagnosis and therapy. Metal-based radiopharmaceuticals are characterized by a radiometal-chelator moiety linked to a bio-vector that binds the biological target (e.g., a...
4.
Macorano A, Mazzolari A, Malloci G, Pedretti A, Vistoli G, Gervasoni S
Sci Data
. 2024 Aug;
11(1):929.
PMID: 39191771
In silico prediction of xenobiotic metabolism is an important strategy to accelerate the drug discovery process, as candidate compounds often fail in clinical phases due to their poor pharmacokinetic profiles....
5.
Galbiati A, Bocci M, Gervasoni S, Prodi E, Malloci G, Neri D, et al.
J Med Chem
. 2024 Jul;
67(15):13392-13408.
PMID: 39079004
Fibroblast activation protein (FAP) is a protein biomarker widely expressed in most solid human malignancies of epithelial origin. In recent years, a number of FAP-targeted small organic radioligands, including OncoFAP,...
6.
Basciu A, Athar M, Kurt H, Neville C, Malloci G, Muredda F, et al.
bioRxiv
. 2024 Jun;
PMID: 38895346
Knowledge of the structures formed by proteins and small molecules is key to understand the molecular principles of chemotherapy and for designing new and more effective drugs. During the early...
7.
Manrique P, Leus I, Lopez C, Mehla J, Malloci G, Gervasoni S, et al.
Commun Chem
. 2024 Apr;
7(1):84.
PMID: 38609430
The ability Gram-negative pathogens have at adapting and protecting themselves against antibiotics has increasingly become a public health threat. Data-driven models identifying molecular properties that correlate with outer membrane (OM)...
8.
Adorinni S, Gentile S, Bellotto O, Kralj S, Parisi E, Cringoli M, et al.
ACS Nano
. 2024 Jan;
18(4):3011-3022.
PMID: 38235673
The divergent supramolecular behavior of a series of tripeptide stereoisomers was elucidated through spectroscopic, microscopic, crystallographic, and computational techniques. Only two epimers were able to effectively self-organize into amphipathic structures,...
9.
Porcu M, Cocco L, Marrosu F, Cau R, Suri J, Qi Y, et al.
Brain Imaging Behav
. 2023 Nov;
18(1):141-158.
PMID: 37955809
To examine the corpus callosum's (CC) integrity in terms of fractional anisotropy (FA) and how it affects resting-state hemispheric connectivity (rs-IHC) and cognitive function in healthy individuals. Sixty-eight healthy individuals...
10.
Gervasoni S, Mehla J, Bergen C, Leus I, Margiotta E, Malloci G, et al.
mBio
. 2023 Jul;
14(4):e0140323.
PMID: 37493633
Transporters of the resistance-nodulation-cell division (RND) superfamily of proteins are the dominant multidrug efflux power of Gram-negative bacteria. The major RND efflux pump of is MexAB-OprM, in which the inner...